Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: mHealth, which encompasses mobile health technologies and interventions, is rapidly evolving in various medical specialties, and its impact is evident in oncology. Mobile technologies are perceived as effective in prevention and as feasible for managing skin cancer, but the diagnostic accuracy of these tools remains in doubt. These drawbacks in the application of mHealth to teledermatology call for intensified research to strengthen its role in dermatology. Objective: The purpose of this review was to describe current trends in research addressing the integration of mHealth into the management of skin cancer by examining evaluations of mHealth and its contributions across the cancer care continuum. Methods: A systematic review framework was applied to the search using the three electronic databases, PubMed, Web of Science, and Embase. We extensively reviewed appropriate studies regarding skin cancer and mobile technology published between 2000 and present. Studies were included if they discussed the role and impact of mobile technology in the management and evaluation of skin cancer. 33 studies were selected for analysis adhering to inclusion and exclusion criteria. Results: Of the 33 studies, 15 studies (45%) assessed the diagnostic accuracy of mobile technology in detecting skin cancer and ten studies (30%) examined the feasibility and acceptability of mobile technology. The remaining studies (24%) concerned skin cancer prevention, early diagnosis, reduced treatment, and follow-up care through mHealth interventions. Not all phases of skin cancer involve mHealth, and not all have been addressed by research. While the focus of current research was skewed toward prevention and diagnosis phases, the treatment and follow-up phases were the least addressed in the literature. Conclusions: The present review extends knowledge not only on the contributions but also on the integration of mHealth technologies in different phases of skin cancer care. To optimize the effectiveness of mHealth in dermatology, larger numbers of robust, evidence-based studies on teledermatology implementations, evenly distributed across the care continuum, should be conducted so that research can be expanded to systematic reviews.